Retraction: Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn
Main Author: | Frontiers Editorial Office |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-06-01
|
Series: | Frontiers in Pharmacology |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00426/full |
Similar Items
-
Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn
by: Kislay Roy, et al.
Published: (2016-07-01) -
Expression of Concern: Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze
by: Frontiers Editorial Office
Published: (2017-06-01) -
Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze
by: Kislay Roy, et al.
Published: (2017-05-01) -
Corrigendum: Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze
by: Kislay Roy, et al.
Published: (2018-12-01) -
Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
by: Frontiers Editorial Office
Published: (2021-05-01)